Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Taxotere, Carboplatin, Herceptin + Pertuzumab|DRUG: Metformin
Sponsor: Qamar Khan